Ranitidine Syrup recalled over manufacturing violations
- Recall date
- November 1, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- American Health Packaging recalls Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only, Distributed by: American Heal…
- Recall number
- D-0631-2020
- FDA classification
- Class II
- Brand / firm
- American Health Packaging
- Sold / distributed
- Nationwide USA
Why it was recalled
CGMP Deviations: Presence of NDMA impurity detected in product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ranitidine Syrup (Ranitidine Oral Solution USP), 15 mg/mL, 150 mg/10 mL per cup, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio. (a) Case of 50 cups (NDC 60687-260-69) (b) Case of 40 cups (NDC 60687-260-23 (c) Unit Dose Cup (NDC 60687-260-69)
Get recall alerts
Free email alert whenever American Health Packaging has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: American Health Packaging